Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CETP | P11597 | 2/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.41 |
| ▸ | HTR3B | O95264 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.41 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | ESRRG | P62508 | 6/20 | 0.40 |
| ▸ | ESRRB | O95718 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAPKAPK2 | P49137 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL17652252 | 0.97 | ALDH1A1 (0.48) | ALDH1A1USP2TSHRHSD17B10CETP | |
| SCHEMBL2704646 | 0.94 | ALDH1A1 (0.45) | ALDH1A1USP2TSHRHSD17B10HTR3E | |
| SCHEMBL23152941 | 0.90 | MAPKAPK2 (0.50) | ALDH1A1USP2TSHRHSD17B10CETP | |
| SCHEMBL18910226 | 0.90 | ADRB1 (0.48) | ALDH1A1USP2TSHRHSD17B10ADRB1 | |
| SCHEMBL8775865 | 0.90 | MAPT (0.48) | ALDH1A1TSHRHSD17B10MEN1KMT2A | |
| SCHEMBL17269404 | 0.89 | HPGD (0.44) | ALDH1A1USP2TSHRHSD17B10SIGMAR1 | |
| SCHEMBL19601159 | 0.89 | LMNA (0.43) | ALDH1A1USP2TSHRHSD17B10MEN1 | |
| SCHEMBL8899012 | 0.89 | NPC1 (0.47) | ALDH1A1TSHRHSD17B10MEN1KMT2A | |
| SCHEMBL18910121 | 0.88 | ALDH1A1 (0.50) | ALDH1A1USP2TSHRHSD17B10HTR3E | |
| SCHEMBL22722496 | 0.88 | NPC1 (0.50) | USP2MEN1KMT2AHTR6HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961405-B2 | Fluorine-containing acetophenone derivative, fluroine based additive, curable composition including same, and cured product thereof | DIC CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| WO-2019198489-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, INSULATING MATERIAL, RESIN MATERIAL FOR SOLDER RESISTS AND RESIST MEMBER | DIC株式会社 | 2019-10-17 | — | — | WO | disclosed |
| EP-2379512-B1 | TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF | NOVARTIS AG (CH) | 2017-03-29 | — | — | EP | disclosed |
| US-8674089-B2 | Michael addition reaction product and active energy ray-curable composition | DIC CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8674089-B2 | Michael addition reaction product and active energy ray-curable composition | DIC CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| EP-1812414-B1 | PIPERAZINO BASED PHOTOINITIATORS | SUN CHEMICAL LTD (GB) | 2012-12-26 | — | — | EP | disclosed |
| US-8324256-B2 | Tri-functional UV-absorbing compounds and use thereof | NOVARTIS AG (CH) | 2012-12-04 | — | — | US | disclosed |
| US-8324256-B2 | Tri-functional UV-absorbing compounds and use thereof | NOVARTIS AG (CH) | 2012-12-04 | — | — | US | disclosed |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC CORPORATION. (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC CORPORATION. (JP) | 2012-07-26 | — | — | US | disclosed |
| WO-2010078001-A1 | TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF | NOVARTIS AG (CH) | 2010-07-08 | — | — | WO | disclosed |
| US-20100168359-A1 | TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF | ALCON INC. (CH) | 2010-07-01 | — | — | US | disclosed |
| US-20100168359-A1 | TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF | ALCON INC. (CH) | 2010-07-01 | — | — | US | disclosed |
| US-7612122-B2 | Piperazino based photoinitiators | SUN CHEMICAL CORPORATION (US) | 2009-11-03 | — | — | US | disclosed |
| US-7612122-B2 | Piperazino based photoinitiators | SUN CHEMICAL CORPORATION (US) | 2009-11-03 | — | — | US | disclosed |
| US-7612122-B2 | Piperazino based photoinitiators | SUN CHEMICAL CORPORATION (US) | 2009-11-03 | — | — | US | disclosed |
| US-20080045620-A1 | Piperazino Based Photoinitiators | SUN CHEMICAL CORPORATION (US) | 2008-02-21 | — | — | US | disclosed |
| US-20080045620-A1 | Piperazino Based Photoinitiators | SUN CHEMICAL CORPORATION (US) | 2008-02-21 | — | — | US | disclosed |
| US-20080045620-A1 | Piperazino Based Photoinitiators | SUN CHEMICAL CORPORATION (US) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168359-A1 | TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF | UACA, TCOF1, TTPA | ALDH1A1 992/4885USP2 615/4885TSHR 2855/4885 |
| US-20080045620-A1 | Piperazino Based Photoinitiators | H1-3, H1-0, H1-2 | ALDH1A1 1937/4885USP2 2452/4885TSHR 2061/4885 |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | PARP14, TIPARP, PARP16 | ALDH1A1 590/4885USP2 3914/4885TSHR 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.